To include your compound in the COVID-19 Resource Center, submit it here.

Telik Phase II cancer results

TELK reported additional results from Phase II studies of its TLK286, a small molecule that induces apoptosis in tumor cells by binding Glutathione S-transferase P1-1 (GST-P1-1).

Read the full 266 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE